SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001070081-23-000028
Filing Date
2023-04-27
Accepted
2023-04-27 16:35:13
Documents
90
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20230331x10q.htm   iXBRL 10-Q 2136787
2 EX-10.1 tmb-20230331xex10d1.htm EX-10.1 573372
3 EX-10.2 tmb-20230331xex10d2.htm EX-10.2 613366
4 EX-31.1 tmb-20230331xex31d1.htm EX-31.1 10920
5 EX-31.2 tmb-20230331xex31d2.htm EX-31.2 10719
6 EX-32.1 tmb-20230331xex32d1.htm EX-32.1 5932
7 EX-32.2 tmb-20230331xex32d2.htm EX-32.2 6115
  Complete submission text file 0001070081-23-000028.txt   12859396

Data Files

Seq Description Document Type Size
8 EX-101.SCH tmb-20230331.xsd EX-101.SCH 77257
9 EX-101.CAL tmb-20230331_cal.xml EX-101.CAL 72510
10 EX-101.DEF tmb-20230331_def.xml EX-101.DEF 399134
11 EX-101.LAB tmb-20230331_lab.xml EX-101.LAB 750310
12 EX-101.PRE tmb-20230331_pre.xml EX-101.PRE 604205
84 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20230331x10q_htm.xml XML 2338298
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

IRS No.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35969 | Film No.: 23857721
SIC: 2834 Pharmaceutical Preparations